Todisco Joseph
Insider CIK 1774807 · CRMD Chief Executive Officer, Director · TLPH Director · AMRX SVP, Specialty Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | A Award deriv | 2026-06-22 | 2026-06-24 | 30,700 | — | $0 | 30,700 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2026-06-22 | 2026-06-24 | 5,100 | — | $0 | 11,497 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2026-02-04 | 2026-02-06 | 77,156 | — | $0 | 774,749 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2026-01-23 | 2026-01-27 | 27,306 | $7.27 | $198.5K | 697,593 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2026-01-23 | 2026-01-27 | 225,900 | — | $0 | 724,899 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2026-01-17 | 2026-01-20 | 22,665 | $6.78 | $153.7K | 498,999 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise deriv | 2026-01-16 | 2026-01-20 | 29,585 | — | $0 | 411,245 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise | 2026-01-16 | 2026-01-20 | 29,585 | $3.38 | $100.0K | 521,664 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2026-01-12 | 2026-01-20 | 17,417 | $7.15 | $124.5K | 492,079 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise deriv | 2025-12-18 | 2025-12-19 | 30,000 | — | $0 | 370,000 | SEC↗ |
| CRMD CorMedix Inc. | S Sale | 2025-12-18 | 2025-12-19 | 30,000 | $12.00 | $360.0K | 509,496 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise | 2025-12-18 | 2025-12-19 | 30,000 | $4.43 | $132.9K | 539,496 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2025-10-15 | 2025-10-16 | 38,381 | — | $0 | 38,381 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2025-10-15 | 2025-10-16 | 6,397 | — | $0 | 6,397 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise deriv | 2025-09-12 | 2025-09-12 | 50,000 | — | $0 | 216,667 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise | 2025-09-12 | 2025-09-12 | 50,000 | $3.47 | $173.5K | 559,496 | SEC↗ |
| CRMD CorMedix Inc. | S Sale | 2025-09-12 | 2025-09-12 | 50,000 | $13.00 | $650.0K | 509,496 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2025-05-10 | 2025-09-12 | 21,225 | $11.66 | $247.5K | 509,496 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise deriv | 2025-04-01 | 2025-04-02 | 59,170 | — | $0 | 440,830 | SEC↗ |
| CRMD CorMedix Inc. | M Exercise | 2025-04-01 | 2025-04-02 | 59,170 | $3.38 | $200.0K | 530,721 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2025-01-17 | 2025-01-22 | 23,977 | $12.17 | $291.8K | 471,551 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2025-01-17 | 2025-01-22 | 187,500 | — | $0 | 495,528 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2025-01-10 | 2025-01-14 | 17,829 | $11.19 | $199.5K | 308,028 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2024-05-10 | 2024-05-13 | 26,982 | $5.17 | $139.5K | 325,857 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2024-03-13 | 2024-03-14 | 13,561 | $3.74 | $50.7K | 352,839 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2024-01-12 | 2024-01-17 | 266,667 | — | $0 | 266,667 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2024-01-12 | 2024-01-17 | 13,781 | $3.47 | $47.8K | 339,278 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2024-01-12 | 2024-01-17 | 133,333 | — | $0 | 353,059 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2023-09-08 | 2023-09-08 | 10,000 | $3.71 | $37.1K | 219,726 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2023-05-17 | 2023-05-17 | 5,000 | $4.58 | $22.9K | 209,726 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2023-05-17 | 2023-05-18 | 5,000 | $4.58 | $22.9K | 209,726 | SEC↗ |
| CRMD CorMedix Inc. | F Tax w/h | 2023-05-10 | 2023-05-12 | 37,443 | $5.30 | $198.4K | 204,726 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2023-01-14 | 2023-01-18 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2022-11-15 | 2022-11-16 | 20,000 | $3.82 | $76.4K | 242,169 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2022-08-24 | 2022-08-25 | 4,700 | $3.92 | $18.4K | 222,169 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2022-05-16 | 2022-05-17 | 10,000 | $3.38 | $33.8K | 217,469 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2022-05-10 | 2022-05-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award | 2022-05-10 | 2022-05-12 | 207,469 | — | $0 | 207,469 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-05-07 | 2022-05-10 | 4,442 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-05-07 | 2022-05-10 | 1,562 | $3.40 | $5.3K | 327,194 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-05-07 | 2022-05-10 | 4,442 | — | $0 | 328,756 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 144,928 | — | $0 | 144,928 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 289,856 | — | $0 | 289,856 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-03-01 | 2022-03-03 | 26,544 | — | $0 | 79,634 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-03-01 | 2022-03-03 | 11,111 | — | $0 | 11,111 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-03-01 | 2022-03-03 | 9,331 | $4.45 | $41.5K | 324,314 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-03-01 | 2022-03-03 | 11,111 | — | $0 | 311,007 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-03-01 | 2022-03-03 | 3,906 | $4.45 | $17.4K | 307,101 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-03-01 | 2022-03-03 | 26,544 | — | $0 | 333,645 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-02-27 | 2022-03-01 | 29,684 | — | $0 | 59,367 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-02-27 | 2022-03-01 | 29,684 | — | $0 | 311,003 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2022-02-27 | 2022-03-01 | 11,107 | $4.59 | $51.0K | 299,896 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2021-12-02 | 2021-12-03 | 1,500 | $4.10 | $6.1K | 281,319 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-05-07 | 2021-05-11 | 4,441 | — | $0 | 4,442 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-05-07 | 2021-05-11 | 4,441 | — | $0 | 284,381 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2021-05-07 | 2021-05-11 | 1,562 | $5.20 | $8.1K | 282,819 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-03-15 | 2021-03-17 | 36,330 | — | $0 | 36,331 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2021-03-15 | 2021-03-17 | 36,330 | $6.82 | $247.8K | 279,940 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-03-15 | 2021-03-17 | 36,330 | $2.75 | $99.9K | 316,270 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-03-01 | 2021-03-02 | 11,111 | — | $0 | 22,222 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 212,356 | — | $0 | 212,356 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-03-01 | 2021-03-03 | 106,178 | — | $0 | 106,178 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-03-01 | 2021-03-02 | 11,111 | — | $0 | 283,846 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2021-03-01 | 2021-03-02 | 3,906 | $5.18 | $20.2K | 279,940 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-02-27 | 2021-03-02 | 29,683 | — | $0 | 89,051 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-02-27 | 2021-03-02 | 29,683 | — | $0 | 283,707 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2021-02-27 | 2021-03-02 | 10,972 | $5.39 | $59.1K | 272,735 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-05-07 | 2020-05-08 | 4,442 | — | $0 | 8,883 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2020-05-07 | 2020-05-08 | 2,212 | $3.55 | $7.9K | 254,024 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-05-07 | 2020-05-08 | 4,442 | — | $0 | 256,236 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-03-01 | 2020-03-03 | 11,111 | — | $0 | 33,333 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2020-03-01 | 2020-03-03 | 6,162 | $3.85 | $23.7K | 251,794 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-03-01 | 2020-03-03 | 11,111 | — | $0 | 257,956 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2020-02-28 | 2020-03-03 | 40,000 | $3.62 | $144.8K | 246,845 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 237,468 | — | $0 | 237,468 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-02-27 | 2020-03-02 | 118,734 | — | $0 | 118,734 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-11-13 | 2019-11-14 | 90,498 | — | $0 | 90,498 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | D To issuer deriv | 2019-11-13 | 2019-11-14 | 90,498 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | D To issuer deriv | 2019-11-13 | 2019-11-14 | 72,661 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-11-13 | 2019-11-14 | 72,661 | — | $0 | 72,661 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2019-05-13 | 2019-05-13 | 15,000 | $9.88 | $148.2K | 205,590 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2019-05-07 | 2019-05-09 | 4,441 | — | $0 | 13,325 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2019-05-07 | 2019-05-09 | 2,228 | $13.44 | $29.9K | 190,590 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2019-05-07 | 2019-05-09 | 4,441 | — | $0 | 192,818 | SEC↗ |